MedtechLedger currently links 32 FDA records to the applicant name Johnson & Johnson Surgical Vision, Inc.. It includes 4 original PMA approvals. 7 entries are PMA supplements. 21 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jan 14, 1983 to Oct 30, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Changes described in PMA records
FDA records show supplement P810031/S083, tied to PMA P810031, was approved on 2026-10-30 for a design change. The supplied statement names the change as a new cannula design for the Healon EndoCoat PRO Sodium Hyaluronate Ophthalmic Viscoelastic Device (OVD).
The supplement scope is limited to use with that OVD in the individual pack and the Healon Duet PRO II Dual Pack. The source does not describe the cannula’s design details, any new indication, or any safety or effectiveness findings; it is a change/design supplement, not a new PMA for the whole system.
FDA approval-order wording
approval for a new cannula design for use with the Healon EndoCoat PRO Sodium Hyaluronate Ophthalmic Viscoelastic Device (OVD) in both the individual pack and the Healon Duet PRO II Dual Pack
Oct 30, 2026 · Real-Time ProcessThe record covers PMA P980040, supplement S186, with a 30-day notice reason listed as a process change affecting manufacturer, sterilizer, packager, or supplier. The stated change is moving microbiology testing from an external contractor to an in-house laboratory supporting product manufacturing at the AMO Puerto Rico site. The listed devices are the SENSAR 3-Piece Monofocal IOL, SENSAR 1-piece IOL, TECNIS Multi-focal 1-pc, TECNIS 1-PC OptiBlue IOL and TECNIS OptiBlue 1-P, product code HQL, applicant Johnson & Johnson Surgical Vision, Inc.
S186 is a supplement to the existing PMA identified by the database, not a new approval of the whole lens system. The source states the intended purpose of the transfer; it does not report microbiology results, testing validation data or an independent finding of safety or effectiveness. The record also does not specify which lens models the in-house laboratory serves, the tests transferred, or the contractor involved.
The decision field reads OK30, dated 2026-10-19. Beyond that label and the notice reason, the supplied fields do not describe the decision's scope or any conditions.
FDA approval-order wording
the transfer of microbiology testing from an external contractor to an in-house laboratory to support product manufacturing at the AMO Puerto Rico manufacturing site
Oct 19, 2026 · 30-Day NoticeFDA database record P990080/S067 describes a 30-day notice for the TECNIS Foldable Acrylic IOL with OptiEdge, Model ZA9003. The stated change is the transfer of microbiology testing from an external contractor to an in-house laboratory to support product manufacturing at the AMO Puerto Rico manufacturing site. The applicant is Johnson & Johnson Surgical Vision, Inc., and the supplement type is a process change involving manufacturer, sterilizer, packager, or supplier.
This supplement does not represent a new approval of the intraocular lens system. The record identifies the original PMA number P990080, but the notice concerns only the reported testing location change. The source statement describes the purpose of the change; it does not provide independent proof of safety or clinical effectiveness. Specific details about validation results, test methods, or manufacturing impact are absent from the supplied fields.
FDA approval-order wording
the transfer of microbiology testing from an external contractor to an in-house laboratory to support product manufacturing at the AMO Puerto Rico manufacturing site
Oct 19, 2026 · 30-Day NoticeThe FDA record for P080010/S032 covers the TECNIS Multi-focal 3-pc, Model ZMA00, a multifocal intraocular lens in the ophthalmic specialty under product code MFK, submitted by Johnson & Johnson Surgical Vision, Inc. The supplement is a 30-Day Notice filed under the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier, and the recorded decision is OK30, dated 2026-10-19.
The recorded change is the transfer of microbiology testing from an external contractor to an in-house laboratory supporting product manufacturing at the AMO Puerto Rico manufacturing site. This notice concerns that testing-location change within the existing application; it is not a new approval of the lens itself. The public documentation includes no documents, so the notice's technical content and any FDA review detail beyond the recorded fields remain unknown.
Whether the in-house laboratory's methods, validation data or inspection outcome were assessed is not stated in the available record, and no clinical or legal conclusion about the device should be drawn from this administrative entry.
FDA approval-order wording
the transfer of microbiology testing from an external contractor to an in-house laboratory to support product manufacturing at the AMO Puerto Rico manufacturing site
Oct 19, 2026 · 30-Day NoticeFDA’s recorded scope: to automate several steps on the manufacturing line of the Healon PRO family of products at the current manufacturing site AMO Uppsala AB (Uppsala, Sweden)
Jul 28, 2026 · 30-Day NoticeSubsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.